The dysregulation of BACE1AS is associated with upregulated BACE1 activity in several human disorders, including Alzheimer’s disease, Parkinson’s disease, heart failure, and MCI, indicating a potential influential role of BACE1AS in the progression of these diseases [23]. This evidence concerns the gene BACE1 and Alzheimer disease.